Yang Tian, Zhen Shi, Jiahao Cai, Chi Hou, Xiuying Wang, Haixia Zhu, . . . Wen-Xiong Chen. (2023). Levetiracetam may be an unsuitable choice for patients with PRRT2-associated self-limited infantile epilepsy. BMC.
Chicago Style (17th ed.) CitationYang Tian, et al. Levetiracetam May Be an Unsuitable Choice for Patients with PRRT2-associated Self-limited Infantile Epilepsy. BMC, 2023.
MLA (9th ed.) CitationYang Tian, et al. Levetiracetam May Be an Unsuitable Choice for Patients with PRRT2-associated Self-limited Infantile Epilepsy. BMC, 2023.
Warning: These citations may not always be 100% accurate.